Issue 32, 2017

C60@lysozyme: a new photosensitizing agent for photodynamic therapy

Abstract

C60@lysozyme showed significant visible light-induced singlet oxygen generation in water, indicating the potential of this hybrid as an agent for photodynamic therapy. The reactive oxygen species (ROS) concentration generated by C60@lysozyme during irradiation depends on the light source, the irradiation time and the concentration of the hybrid. C60@lysozyme significantly reduced the HeLa cell viability in response to visible light irradiation. The generation of H2O2, due to the photoactivity of C60@lysozyme, causes cell death via easy permeation of hydrogen peroxide through the cell membrane and activation of endogenous ROS production.

Graphical abstract: C60@lysozyme: a new photosensitizing agent for photodynamic therapy

Supplementary files

Article information

Article type
Paper
Submitted
23 mar. 2017
Accepted
27 apr. 2017
First published
27 apr. 2017

J. Mater. Chem. B, 2017,5, 6608-6615

C60@lysozyme: a new photosensitizing agent for photodynamic therapy

A. Soldà, A. Cantelli, M. Di Giosia, M. Montalti, F. Zerbetto, S. Rapino and M. Calvaresi, J. Mater. Chem. B, 2017, 5, 6608 DOI: 10.1039/C7TB00800G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements